0001673368-17-000001.txt : 20170512 0001673368-17-000001.hdr.sgml : 20170512 20170512121400 ACCESSION NUMBER: 0001673368-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 EFFECTIVENESS DATE: 20170512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DalCor Pharmaceuticals Canada Inc. CENTRAL INDEX KEY: 0001673372 IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-263148-01 FILM NUMBER: 17837361 BUSINESS ADDRESS: STREET 1: 1010 SHERBROOKE ST. WEST, SUITE 408 CITY: MONTREAL STATE: A8 ZIP: H3A 2R7 BUSINESS PHONE: 514-564-6474 MAIL ADDRESS: STREET 1: 1010 SHERBROOKE ST. WEST, SUITE 408 CITY: MONTREAL STATE: A8 ZIP: H3A 2R7 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DalCor Pharmaceuticals US, LLC CENTRAL INDEX KEY: 0001673368 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-263148 FILM NUMBER: 17837362 BUSINESS ADDRESS: STREET 1: 400 S. EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 400 S. EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 D/A 1 primary_doc.xml X0707 D/A LIVE 0001673368 DalCor Pharmaceuticals US, LLC 400 S. EL CAMINO REAL, SUITE 1200 SAN MATEO CA CALIFORNIA 94402 650-401-2000 DELAWARE None None Limited Liability Company true 2015 0001673372 DalCor Pharmaceuticals Canada Inc. 1010 SHERBROOKE ST. WEST, SUITE 408 MONTREAL A8 QUEBEC, CANADA H3A 2R7 514-564-6474 QUEBEC, CANADA None None Corporation true 2015 Robert McNeil c/o DalCor Pharmaceuticals US, LLC 400 S. El Camino Real, Suite #1200 San Mateo CA CALIFORNIA 94402 Executive Officer Director Promoter Dr. McNeil is an Executive Officer and Director of DalCor Pharmaceuticals Canada Inc., a Manager of DalCor Pharmaceuticals US, LLC and a Promoter of both DalCor Pharmaceuticals Canada Inc. and DalCor Pharmaceuticals US, LLC. D. Michael Dixon c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Executive Officer Director Mr. Dixon is an Executive Officer of DalCor Pharmaceuticals Canada Inc. and a Manager of DalCor Pharmaceuticals US, LLC. Mark Smith c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Director Mr. Smith is a Director of DalCor Pharmaceuticals Canada Inc. Laurence Rulleau c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Director Ms. Rulleau is a Director of DalCor Pharmaceuticals Canada Inc. Rody Yared c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Director Mr. Yared is a Director of DalCor Pharmaceuticals Canada Inc. Thomas Birch c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Director Mr. Birch is a Director of DalCor Pharmaceuticals Canada Inc. Ga?tan Gravel c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Director Mr. Gravel is a Director of DalCor Pharmaceuticals Canada Inc. Louise Proulx c/o DalCor Pharmaceuticals Canada Inc. 1010 Sherbrooke St. West, Suite #408 Montreal A8 QUEBEC, CANADA H3A 2R7 Executive Officer Ms. Proulx is an Executive Officer of DalCor Pharmaceuticals Canada Inc. Pharmaceuticals Decline to Disclose 06b true 0001673372-16-000001 2016-04-29 true true false 0 110000000 55000000 55000000 false 47 0 0 0 false DalCor Pharmaceuticals US, LLC /s/ D. Michael Dixon D. Michael Dixon Manager 2017-05-12 DalCor Pharmaceuticals Canada Inc. /s/ D. Michael Dixon D. Michael Dixon Chief Financial Officer 2017-05-12